Optimisation of conformal radiation therapy by intensity modulation: cancer of the larynx and salivary gland function (Q33186963)

23 July 2017

title

Optimisation of conformal radiation therapy by intensity modulation: cancer of the larynx and salivary gland function (English)

1 reference

adaptive radiation therapy

23 July 2017

main subject

0 references

0 references

1 reference

Mirjam M J Braaksma

1

1 reference

23 July 2017

Oda B Wijers

2

1 reference

23 July 2017

John R van Sörnsen de Koste

3

1 reference

23 July 2017

Henrie van der Est

4

1 reference

23 July 2017

Paul I M Schmitz

5

1 reference

23 July 2017

Peter J C M Nowak

6

1 reference

23 July 2017

Peter C Levendag

7

1 reference

23 July 2017

publication date

1 March 2003

1 reference

Radiotherapy and Oncology

23 July 2017

published in

1 reference

23 July 2017

volume

66

1 reference

23 July 2017

issue

3

1 reference

23 July 2017

page(s)

291-302

1 reference

The utility of SPECT in determining the relationship between radiation dose and salivary gland dysfunction after radiotherapy.

23 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900038-0

7 January 2021

Recent randomized trials of chemoradiation in the management of locally advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900038-0

7 January 2021

Mature results of a phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with stage III and IV squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900038-0

7 January 2021

Altered fractionation in the management of head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900038-0

7 January 2021

Clinical radiobiology of squamous cell carcinoma of the oropharynx

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900038-0

7 January 2021

Long-term follow-up of patients treated with acupuncture for xerostomia and the influence of additional treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900038-0

7 January 2021

Prognostic value of the pilocarpine test to identify patients who may obtain long-term relief from xerostomia by acupuncture treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900038-0

7 January 2021

A randomized study of very accelerated radiotherapy with and without amifostine in head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900038-0

7 January 2021

Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900038-0

7 January 2021

Phase III randomized trial of amifostine as a radioprotector in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900038-0

7 January 2021

Selective cytoprotection with amifostine in concurrent radiochemotherapy for head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900038-0

7 January 2021

Parotid and submandibular/sublingual salivary flow during high dose radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900038-0

7 January 2021

Intensity-modulated radiation therapy in head and neck cancers: The Mallinckrodt experience

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900038-0

7 January 2021

A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900038-0

7 January 2021

The function of the parotid gland following radiation therapy for head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900038-0

7 January 2021

Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900038-0

7 January 2021

Beam intensity modulation using tissue compensators or dynamic multileaf collimation in three-dimensional conformal radiotherapy of primary cancers of the oropharynx and larynx, including the elective neck

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900038-0

7 January 2021

Field margin reduction using intensity-modulated x-ray beams formed with a multileaf collimator

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900038-0

7 January 2021

Beam intensity modulation for penumbra enhancement and field length reduction in lung cancer treatments: a dosimetric study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900038-0

7 January 2021

Comprehensive irradiation of head and neck cancer using conformal multisegmental fields: assessment of target coverage and noninvolved tissue sparing

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900038-0

7 January 2021

Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900038-0

7 January 2021

Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900038-0

7 January 2021

Studies on human minor salivary gland secretions using the Periotron method.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900038-0

7 January 2021

Confirmation of improved local-regional control with altered fractionation in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900038-0

7 January 2021

Subjective reports of xerostomia and objective measures of salivary gland performance

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900038-0

7 January 2021

Optimization and clinical use of multisegment intensity-modulated radiation therapy for high-dose conformal therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900038-0

7 January 2021

A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900038-0

7 January 2021

Determination of variation of stimulated salivary flow rates

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900038-0

7 January 2021

Radiation-induced xerostomia: pathophysiology, clinical course and supportive treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900038-0

7 January 2021

Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900038-0

7 January 2021

Post-radiation severe xerostomia relieved by pilocarpine: a prospective French cooperative study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900038-0

7 January 2021

A simple method to estimate the secretion of saliva from minor salivary glands using iodine-starch reaction.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900038-0

7 January 2021

The efficacy of Xialine in patients with xerostomia resulting from radiotherapy for head and neck cancer: a pilot-study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900038-0

7 January 2021

Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900038-0

7 January 2021

Acupuncture for pilocarpine-resistant xerostomia following radiotherapy for head and neck malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900038-0

7 January 2021

Altered fractionation: limited by mucosal reactions?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900038-0

7 January 2021

Improved results with accelerated hyperfractionated radiotherapy of advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900038-0

7 January 2021

Parotid gland function following accelerated and conventionally fractionated radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900038-0

7 January 2021

A multicenter, randomized, double-blind, placebo-controlled, dose-titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900038-0

7 January 2021

Has the outlook improved for amifostine as a clinical radioprotector?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900038-0

7 January 2021

Preliminary results of a pilot study using WR-2721 before fractionated irradiation of the head and neck to reduce salivary gland dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900038-0

7 January 2021

A three-dimensional CT-based target definition for elective irradiation of the neck

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900038-0

7 January 2021

Oral pilocarpine for radiation-induced xerostomia: integrated efficacy and safety results from two prospective randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900038-0

7 January 2021

Quantitative dose-volume response analysis of changes in parotid gland function after radiotherapy in the head-and-neck region.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900038-0

7 January 2021

Effect of Radiotherapy on Whole Saliva Flow

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900038-0

7 January 2021

Radiosensitivity of the Human Parotid Gland

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900038-0

7 January 2021

How much saliva is enough? 'Normal' function defined

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900038-0

7 January 2021

Measurements of human minor salivary gland secretions from different oral sites

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900038-0

7 January 2021

Randomized clinical trial on 7-day-continuous accelerated irradiation (CAIR) of head and neck cancer - report on 3-year tumour control and normal tissue toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900038-0

7 January 2021

Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900038-0

7 January 2021

Toxicity in head and neck cancer: a review of trends and issues

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900038-0

7 January 2021

Effect of amifostine on patient assessed clinical benefit in irradiated head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900038-0

7 January 2021

Patients with head and neck cancer cured by radiation therapy: a survey of the dry mouth syndrome in long-term survivors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900038-0

7 January 2021

A simplified CT-based definition of the lymph node levels in the node negative neck

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900038-0

7 January 2021

Oral pilocarpine: a review of its pharmacological properties and clinical potential in xerostomia

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900038-0

7 January 2021

Analysis of residual saliva and minor salivary gland secretions

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900038-0

7 January 2021

The potential for sparing of parotids and escalation of biologically effective dose with intensity-modulated radiation treatments of head and neck cancers: a treatment design study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900038-0

7 January 2021

Concomitant pilocarpine during head and neck irradiation is associated with decreased posttreatment xerostomia

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900038-0

7 January 2021

10.1016/S0167-8140(03)00038-0

Identifiers

DOI

1 reference

23 July 2017

1 reference